Optimizing Y90 Therapy for Radiation Lobectomy
NCT: NCT04390724 · ACTIVE_NOT_RECRUITING
광고
NCT IDNCT04390724
상태ACTIVE_NOT_RECRUITING
시작일2020-07-17
완료2026-11-27
SponsorNorthwestern University (OTHER)
First posted
Last updated
간략 요약
HCC resection candidates with inadequate future liver remnant will be enrolled in this study. They will be treated with Y90 radioembolization to help grow the liver enough to undergo liver resection. There will be 2 Patient Groups. The first group of patients will be treated with Y90 dose and embolic load as per standard-of-care. The second group of patients will be treated with the optimal Y90 dose and embolic load found in Patient Group 1.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.